TWD
BBIO icon

True Wealth Design’s BridgeBio Pharma BBIO Stock Holding History

True Wealth Design’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.64K Hold
116
– – ﹤0.01% 1116
2026
Q1 		$8.62K Hold
116
– – ﹤0.01% 1026
2025
Q4 		$8.87K Sell
116
-3
-3% -$197 ﹤0.01% 904
2025
Q3 		$6.18K Hold
119
– – ﹤0.01% 1001
2025
Q2 		$5.14K Buy
119
+26
+28% +$946 ﹤0.01% 794
2025
Q1 		$3.22K Buy
93
+9
+11% +$303 ﹤0.01% 828
2024
Q4 		$2.31K Sell
84
-124
-60% -$3.21K ﹤0.01% 702
2024
Q3 		$5.3K Buy
+208
New +$5.46K ﹤0.01% 541

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

True Wealth Design's BBIO Position: Q2 2026 in Review

True Wealth Design held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 116 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

True Wealth Design first reported a position in BBIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.87K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • True Wealth Design held 116 shares of BridgeBio Pharma worth $8.64K as of Q2 2026.
  • True Wealth Design left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1116 holding.
  • True Wealth Design first reported a position in BridgeBio Pharma in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's BridgeBio Pharma position peaked at $8.87K in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.